News &
Events

CEO Update: August 2021

CEO Update: August 2021

InSitu Biologics has had a very productive summer. We received positive pre-clinical animal study results on our lead product, had...

read more
CEO Update: April 2021

CEO Update: April 2021

InSitu Biologics is off to a fast start in 2021.  We completed a successful financing round, made great strides in our R&D efforts,...

read more
CEO Update: December 2020

CEO Update: December 2020

Insitu Biologics had several key accomplishments in 2020, setting the stage for an even better 2021. We significantly reduced our...

read more
CEO Update: August 2020

CEO Update: August 2020

InSitu Biologics has made considerable progress executing our business plan over the past several months, even in the midst of ongoing...

read more
CEO Update: April 2020

CEO Update: April 2020

InSitu Biologics has continued to make great strides over the past few months. We have successfully submitted our Pre-IND application...

read more